Dergiler / Retina-Vitreus / 2022 / Cilt: 31 - Sayı: 3

A Rare Differential Diagnosis of Neovascular Age-Related Macular Degeneration: Choroidal Metastasis

Sayfa
281–284
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Despite being rare, choroidal metastasis should be considered as a differential diagnosis of n-AMD.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:We present the case of 80-year-old patient with choroidal metastasis that was initially misdiagnosed as neovascular age-related macular degeneration (n-AMD) because of the presence of subretinal fluid.
📊
Temel Bulgular & Veri:Three doses of intravitreal aflibercept (AFL) were administered with 9 concurrent cycles of systemic chemotherapy over 13 months.
💡
Sonuç & Katkı:Despite being rare, choroidal metastasis should be considered as a differential diagnosis of n-AMD.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

We present the case of 80-year-old patient with choroidal metastasis that was initially misdiagnosed as neovascular age-related macular degeneration (n-AMD) because of the presence of subretinal fluid. He received four intravitreal ranibizumab injections within six months before he was referred to our retina clinic due to unresponsiveness. A clinical diagnosis of choroidal metastasis from an advanced pulmonary adenocarcinoma was made with an interdisciplinary approach. Three doses of intravitreal aflibercept (AFL) were administered with 9 concurrent cycles of systemic chemotherapy over 13 months. Visual acuity improved from 20/125 to 20/63; complete resolution of the mass was obtained with residual pigmentary and atrophic changes. This regression was sustained during follow-up period, even though the systemic disease progressed. This is the first report of successful combination therapy of intravitreal AFL and systemic chemotherapy. Despite being rare, choroidal metastasis should be considered as a differential diagnosis of n-AMD.

🔖

Bu Makaleye Atıf Yap

KANRA, A. Y. (2022). A Rare Differential Diagnosis of Neovascular Age-Related Macular Degeneration: Choroidal Metastasis. Retina-Vitreus, Cilt: 31 - Sayı: 3, 281–284. https://ajindex.com/articles/589009

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (8)

  1. Shields CL, Shields JA, Gross NE, et al. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997;104(8):1265– 1276
  2. Ferry AP, Font RL. Carcinoma metastatic to the eye and orbit. I.A clinicopathologic study of 227 cases. Arch Ophthalmol. 1974; 92: 276-86 3- Arepalli S, Kaliki S, Shields CL. Choroidal metastases: Origin, features, and therapy. Indian J Ophthalmol. 2015 Feb; 63(2): 122–127
  3. Shah SU, Mashayekhi A, Shields CL, et al. Uveal metastasis from lung cancer: Clinical features, treatment, and outcome in 194 patients. Ophthalmology. 2014;121:352–7
  4. Demirci H, Shields CL, Chao AN, et al. Uveal metastasis from breast cancer in 264 patients. Am J Ophthalmol. 2003;136:264– 71
  5. Rudoler SB, Corn BW, Shields CL, et al. External beam irradiation for choroid metastases: identification of factors predisposing to long-term sequelae. Int J Radiat Oncol Biol Phys. 1997; 38: 251-6 7- Detorakis ET, Agorogiannis G, Drakonaki EE, et al. Successful management of choroidal metastasis with intravitreal ranibizumab injections.Ophthalmic Surg Lasers Imaging. 2012 May 24;43 8- Lauro S, Onesti CE, Righini R, et al. The use of bevacizumab in non-small cell lung cancer: an update. Anticancer Res. 2014;34:1537–45
  6. Ohr M, Kaiser PK. Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration. Expert Opin Pharmacother 2012; 13: 585-591
  7. Browning DJ, Kaiser PK, Rosenfeld PJ, et al. Aflibercept for age-related macular degeneration: a game changer or quiet addition? Am J Ophthalmol 2012; 154: 222-226
  8. Maudgil A, Sears KS, Rundle DA, et al. Failure of intravitreal bevacizumab in the treatment of choroidal metastasis. Eye (Lond) 2015;29(5):707–11.